This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Actinomycosis (pulmonary)

Authoring team

Pulmonary actinomycosis accounts for 15-20% of cases.

  • may result from
    • aspiration of oropharyngeal secretions
    • oesophageal perforation
    • local spread from cervicofacial or abdominal infection
    • haematogenous spread.
  • a higher incidence of pulmonary actinomycosis is seen in patients with underlying lung disease such as emphysema, chronic bronchitis, and bronchiectasis
  • it may coexist with lung disease such as tuberculosis or malignancy making the diagnosis and treatment challenging
    • initial clinical picture may be similar to pneumonia with a low-grade fever, cough, shortness of breath, and chest pain
    • however, there is usually a longer history of illness and associated weight loss and haemoptysis.
  • complications may include:
    • empyema necessitans (a rare complication of empyema in which the pleural infection spreads to affect the soft tissues of the chest wall)
    • pleural effusion
    • mediastinal invasion
      • can progress into the heart causing pericarditis (commonly)
    • rib destruction
    • less often myocarditis or endocarditis may occur either via extension from the pericardium or by haematogenous spread (1)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.